Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation

By H. Lewis, J. Liddle, J. Coote, S. Atkinson, M. Barker, B. Bax, Kevin L. Bicker, Ryan P. Bingham, M. Campbell, Yu Hua Chen and 23 more. Nature Chemical Biology, 2015

716 citations recorded by the source corpus.

PAD4 has been strongly implicated in the pathogenesis of autoimmune, cardiovascular and oncological diseases, through clinical genetics and gene disruption in mice. Novel, selective PAD4 inhibitors binding to a calcium-deficient form of the PAD4 enzyme have, for the first time, validated the critical enzymatic role of human and mouse PAD4 in both histone citrullination and neutrophil extracellular trap formation. The therapeutic potential of PAD4 inhibitors can now be explored.

Subfields: Cancer Research, Immunology, Immunology and Allergy

View Paper: https://www.semanticscholar.org/paper/8a9837801dff8fa772d36c323b4bedcaf75e8f12

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

  1. V. Brinkmann
  2. Arturo Zychlinsky
  3. P. Kubes
  4. V. Papayannopoulos
  5. N. Borregaard
  6. A. Mócsai
  7. B. Yipp
  8. K. Martinod

In Immunology and Allergy

  1. Arturo Zychlinsky

Citations in the corpus